TickerFacts.

Compare

UL Solutions Inc. vs NeoGenomics Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearUL Solutions Inc.
ULS		NeoGenomics Inc
NEO
Year ended2025-12-312025-12-31
Revenue$3.05B$727.33M
Revenue growth (YoY)+6.4%+10.1%
Gross margin49.5% (computed)43.2%
Operating margin17.1%-15.9%
Net margin10.6%-14.9%
Net income$325.00M-$108.03M
EPS (Diluted)$1.60n/a
Operating cash flow$600.00M$5.23M
Free cash flow$403.00M-$21.78M
Cash & equivalents$295.00M$159.62M
Total assets$2.92B$1.36B
Total liabilities$1.63B$523.27M
Shareholders' equity$1.29B$836.56M
Return on year-end equity25.1%-12.9%
Shares outstanding201.03M128.15M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearUL Solutions Inc.NeoGenomics Inc
Latest$3.05B
Ended 2025-12-31		$727.33M
Ended 2025-12-31
1 year earlier$2.87B
Ended 2024-12-31		$660.57M
Ended 2024-12-31
2 years earlier$2.68B
Ended 2023-12-31		$591.64M
Ended 2023-12-31
3 years earlier$2.52B
Ended 2022-12-31		$509.73M
Ended 2022-12-31
4 years earliern/a$484.33M
Ended 2021-12-31